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Smoke-Free Air:
An Important Strategy to Reduce Heart Attacks
Crystal E. Tan , Stanton A. Glantz 
San Francisco, CA, USAIn September 2011, the United Nations held a
high-level meeting (heads of state) at which it
was concluded that the global burden of noncom-
municable diseases posed a threat to development
and that reducing tobacco use (together with un-
healthy diet, physical inactivity, and harmful use
of alcohol) was key to reducing the growing global
burden of heart and other noncommunicable dis-
eases [1]. Although it is widely accepted that tobac-
co is responsible for a significant disease burden and
that reducing tobacco use will reduce these diseases
[2], it is less well-appreciated that reducing expo-
sure to secondhand tobacco smoke produces large
and rapid reductions in heart disease-related events,
including hospitalization for acute myocardial
infarction (AMI) [3].
Secondhand smoke (SHS) is a combination of
the sidestream smoke from the lit end of a burning
cigarette and smoke exhaled by smokers. It is a
complex mixture of particles and gases, many of
which are cardiac toxicants or irritants. SHS is rich
in very fine respiratory suspended particulates that
promote atherosclerosis and trigger heart attacks
[4], so it is not surprising that, in 2005, the Califor-
nia Environmental Protection Agency [5] and, in
2006, the U.S. Surgeon General concluded that
SHS causes coronary heart disease morbidity and
mortality [6], with exposure being associated with
a 25–30% increased risk. This finding is consistent
with the fact that involuntary smokers experience
oxidative stress, systemic inflammation, abnormal
platelet activation and thrombosis, vascular endo-
thelial dysfunction, and a lowered high-density
lipoprotein/low-density lipoprotein ratio, andThe authors have reported they have no relationships relevant to the conten
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sclerosis, as well as autonomic abnormalities of
the heart and vasculature that may trigger a cardiac
event [7,8]. Even though SHS is richer in many
toxins than mainstream smoke, which is inhaled
by smokers [9], it is more diluted so involuntary
smokers are exposed to substantially smaller doses
of these toxins than active smokers are. As a result,
the 25–30% increase in risk of a cardiac event in
involuntary smokers may seem large (compared
with the risk of active smoking of 39% for 1 ciga-
rette/day and 78% for 20 cigarettes/day [10]). The
explanation for these findings is that the response
of the cardiovascular system to the toxins in tobacco
smoke is highly nonlinear, with large incremental
effects at low doses that tend to saturate at higher
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Given what we know about the biology, we would
expect that policies that eliminate SHS exposure
should have a substantial effect on cardiac events,
something first observed in Helena, Montana
(USA), where there was a substantial drop in hos-
pital admissions for AMI following implementa-
tion of a comprehensive (workplaces, restaurants,
and bars) 100% smoke-free law [12]. By 2009, this
literature had grown to 13 studies, which were the
subject of 2 meta-analyses [13,14], which con-
cluded that there was a 14–17% reduction in hospi-
tal admissions for AMIs 1 year after implementingts of this article to disclose.
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year, another meta-analysis [15] found a 10%
reduction in an expanded set of cardiac outcomes
(AMI, acute coronary syndrome, coronary heart
disease, and ischemic heart disease). Since then,
the evidence that comprehensive smoke-free laws
are followed by reductions in AMIs has continued
to accumulate rapidly.
There have also been similar studies of the ef-
fects of these laws on hospital admissions for other
cardiac outcomes––angina [16–20], acute coronary
syndrome [21–24], acute coronary events [25],
ischemic heart disease [26], coronary heart disease
[27], and sudden cardiac death [28]––which also
show immediate reductions in events.
Not surprisingly, the tobacco companies have
mounted a campaign to undermine the evidence
linking smoking and SHS to heart disease. They
conducted early experiments examining these links,
and when results showed positive results unfavor-
able to the tobacco companies, they disputed and
ultimately defunded the research; more recently,
large studies examining SHS exposure and cardio-
vascular disease have presented findings that are
negative or suggest a lower magnitude of effect
due to misclassification [29]. Consistent with this
pattern of behavior, a 2011 meta-analysis by a
long-time tobacco industry consultant [30], funded
by Japan Tobacco International, estimated a smal-
ler effect, but even he could not deny that SHS is
associated with a reduction in AMI. (Studies
funded by the tobacco industry consistently find
smaller or no risks associated with SHS [31].)CONC LU S I ON S
As of 2004, an estimated 40% of children, 33% of
nonsmoking men, and 35% of nonsmoking women
were exposed to SHS globally [32]. Six hundred
thousand deaths worldwide per year are attribut-
able to SHS, translating to 10.9 million disabil-
ity-adjusted life-years lost [32].Comprehensive smoke-free laws that prohibit
smoking in workplaces, restaurants, bars, and casi-
nos represent an opportunity to protect the public
health by reducing the risk of cardiovascular dis-
ease and other SHS-related diseases. When laws
are not comprehensive and permit smoking in
any public place, such as bars or casinos, or in
some sections of an otherwise smoke-free estab-
lishment, they are less effective. For example,
workplace policies that permit smoking in some
areas are about half as effective in reducing con-
sumption and smoking prevalence as fully
smoke-free workplace policies [33]. The people
who work and play in these settings are deprived
of the full cardiovascular benefits of a smoke-free
environment [34]; therefore, exceptions or loop-
holes in smoke-free laws raise an issue of justice
in public health ethics.
As of 2009, 89% of the world’s population lived
without comprehensive smoke-free laws [35].
Although there has been progress since then, much
remains to be done. The World Health Organiza-
tion Framework Convention on Tobacco Control
[36], which had 174 parties as of January 2012,
commits parties to implementing smoke-free
legislation:
Each Party shall adopt and implement in areas of
existing national jurisdiction as determined by
national law and actively promote at other jurisdic-
tional levels the adoption and implementation of
effective legislative, executive, administrative, and/or
other measures, providing for protection from expo-
sure to tobacco smoke in indoor workplaces, public
transport, indoor public places, and, as appropriate,
other public places. (Article 8) [36]
Strongly enforced, comprehensive smoke-free leg-
islation will prevent morbidity and mortality asso-
ciated with SHS, and countries that have not
already implemented such policies should consider
doing so for the protection and well-being of their
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